To determine whether EORTC QLQ-C30/QLQ-OG25 and FACT-E compared longitudinally provide similar reflections of health-related quality of life (HRQOL).
Eighty-six esophageal cancer patients treated with curative intent, scheduled to complete both questionnaires at baseline and post-treatment time points until 36 months. A generalized estimating equation model utilizing a Gaussian family compared instruments longitudinally. The two-one-sided-test (TOST) method assessed equivalence between the instruments.
Trajectories for social domain and overall quality of life differed significantly between instruments. Also, FACT-G’s functional well-being post-treatment returns to baseline 3–6 months earlier than the EORTC QLQ-C30’s role functioning subscale, suggesting measurement of different components. Trajectories for physical and esophageal symptom subscales are similar and are deemed equivalent. Emotional domains are comparable and bear little resemblance to the physical domain trajectories indicating reflection of emotional experience rather than a physical proxy. EORTC QLQ-C30 subscales have a trajectory similar to its physical functioning scale except for the emotional and esophageal symptoms scales. Overall HRQOL in both instruments showed a consistent return to baseline/pre-treatment levels by 6 months post-treatment.
Overall HRQOL recovers earlier after curative-intent treatment than previously reported despite persistence of physical symptoms, with a consistent return to pre-treatment levels by 6 months after treatment. This supports the concept that HRQOL is not primarily defined by physical function. Based on this longitudinal comparison, FACT-E provides a more multidimensional assessment of HRQOL.
Implications for Cancer Survivors
Curative intent treatment for esophageal cancer has adverse effects on HRQOL but despite intense treatment, overall HRQOL recovers within 6 months.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Darling GE. Quality of life in patients with esophageal cancer. Thorac Surg Clin. 2013;23:569–75.
Hurmuzlu M, Aarstad HJ, Aarstad AKH, Hjermstad MJ, Viste A. Health-related quality of life in long-term survivors after high-dose chemoradiotherapy followed by surgery in esophageal cancer. Dis Esophagus. 2011;24(1):39–47.
Lagergren J, Lagergren P. Oesophageal cancer. BMJ. 2010;341:c6280. https://doi.org/10.1136/bmj.c6280.
Lagergren J, Smyth E, Cunningham D, Lagergren P. Oesophageal cancer. Lancet. 2017;390:2383–96.
Schandl A, Lagergren J, Johar A, Lagergren P. Health-related quality of life 10 years after oesophageal cancer surgery. Eur J Cancer. 2016;69:43–50.
Conroy T, Marchal F, Blazeby JM. Quality of life in patients with oesophageal and gastric cancer. An overview. Oncology. 2006;70:391–402.
Parameswaran R, McNair A, Avery KNL, Berrisford RG, Wajed SA, Sprangers MAG, et al. The role of health-related quality of life outcomes in clinical decision making in surgery for esophageal cancer: a systematic review. Ann Surg Oncol. 2008;15(9):2372–9.
Parameswaran R, Blazeby JM, Hughes R, Mitchell K, Berrisford RG, Wajed SA. Health-related quality of life after minimally invasive oesophagectomy. Br J Surg. 2010;97(4):525–31.
Whistance RN, Blazeby JM. Systematic review: quality of life after treatment for upper gastrointestinal cancer. Curr Opin Support Palliat Care. 2011;5(1):37–46.
Blazeby JM, Avery K, Sprangers M, Pikhart H, Fayers D, et al. Health-related quality of life measurement in randomized clinical trials in surgical oncology. J Clin Oncol. 2006;24(19):3178–86.
Efficace F, Osoba D, Gotay C, Sprangers M, Coens C, Bottomley A. Has the quality of health-related quality of life reporting in cancer clinical trials improved over time? Towards bridging the gap with clinical decision making. Ann Oncol. 2007;18(4):775–81.
Reynolds JV, McLaughlin R, Moore J, Rowley S, Ravi N, Byrne PJ. Prospective evaluation of quality of life in patients with localized oesophageal cancer treated by multimodality therapy or surgery alone. Br J Surg. 2006;93(9):1084–90.
Scarpa M, Valente S, Alfieri R, Cagol M, Diamantis G, Ancona E, et al. Systematic review of health-related quality of life after esophagectomy for esophageal cancer. World J Gastroenterol. 2011;17(42):4660–74.
Garcia SF, Cella D, Clauser SB, Flynn KE, Lad T, et al. Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative. J Clin Oncol. 2007;25:5106–12.
Trudel JG, Sulman J, Atenafu EG, Kidane B, Darling GE. Longitudinal evaluation of trial outcome index scores in patients with esophageal cancer. Ann Thorac Surg. 2016;102(1):269–75.
Kidane B, Sulman J, Xu W, Kong Q, Wong R, et al. Baseline measure of health-related quality of life (functional assessment of cancer therapy-esophagus) is associated with overall survival in patients with esophageal cancer. J Thorac Cardiovasc Surg. 2016;151(6):1571–80.
Kidane B, Sulman J, Xu W, Kong Q, Wong R, Knox JJ, et al. Pretreatment quality-of-life score is a better discriminator of oesophageal cancer survival than performance status. Eur J Cardiothorac Surg. 2017;51:148–54.
Holzner B, Bode RK, Hahn EA, Cella D, Kopp M, Sperner-Unterweger B, et al. Equating EORTC QLQ-C30 and FACT-G scores and its use in oncological research. Eur J Cancer. 2006;42(18):3169–77.
Blazeby JM, Kavadas V, Vickery CW, Greenwood R, Berrisford RG, Alderson D. A prospective comparison of quality of life measures for patients with esophageal cancer. Qual Life Res. 2005;14(2):387–93.
Luckett T, King MT, Butow PN, Oguchi M, Rankin N, Price MA, et al. Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and recommendations. Ann Oncol. 2011;22(10):2179–90.
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–76.
Blazeby JM, Alderson D, Winstone K, Steyn R, Hammerlind E, et al. Development of a EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. Eur J Cancer. 1996;32A:1912–7.
Lagergren P, Fayers P, Conroy T, Stein HJ, Sezer O, Hardwick R, et al. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach. Eur J Cancer. 2007;43(14):2066–73.
Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11(3):570–9.
Cella D. Manual for the functional assessment of chronic illness therapy (FACIT) measurement system. Elmhurst, Illinois : FACIT.org; 2012.
Darling G, Eton DT, Sulman J, Casson AG, Cella D. Validation of the functional assessment of cancer therapy esophageal cancer subscale. Cancer. 2006;107(4):854–63.
Cella D. Manual of the functional assessment of chronic illness therapy (FACIT) measurement system version 4. Evanston, Illinois: Center on Outcomes, Research and Education (CORE), Evanston Northwestern Healthcare and Northwestern University; 1997.
Webster K, Cella D, Yost K. The functional assessment of chronic illness therapy (FACIT) measurement system: properties, applications, and interpretation. Health Qual Life Outcomes. 2003;1:79. https://doi.org/10.1186/1477-7525-1-79.
Fayers P, Aaronson NK, Bjordal K. Sullivan K (EORTC study group on quality of life). EORTC QLQ-C30 scoring manual. Quality of Life Unit, EORTC Data Centre: Brussels; 1995.
Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13–22.
Prentice RL, Zhao LP. Estimating equations for parameters in means and covariances of multivariate discrete and continuous responses. Biometrics. 1991;47:825–39.
Lenth R.. emmeans: Estimated marginal means, aka least-squares means. R package version 1.4.5. 2020. https://CRAN.R-project.org/package=emmeans. Accessed 30 March 2020
Statistical Analyses Software (SAS) Institute. Base SAS ® 9.3 Procedures guide. Cary, North Carolina : SAS Institute Inc; 2011.
R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2018. https://www.R-project.org. Accessed 30 March 2020
Hinz A, Einenkel J, Briest S, Stolzenburg J-U, Papsdorf K, et al. Is it useful to calculate sum scores of the quality of life questionnaire EORTC QLQ-C30? Eur J Cancer Care. 2012;21(5):677–83.
National Center for Chronic Disease Prevention and Health Promotion | Division of Population Health, Centers Disease Control and Prevention (CDC). Health-Related Quality of Life (HRQOL). 2016. https://www.cdc.gov/hrqol/concept.htm. . Accessed 23 April 2020
Ferrans CE. Definitions and conceptual models of quality of life. In: Lipscomb J, Gotay CC, Snyder C, editors. Outcomes assessment in cancer. Cambridge: Cambridge University; 2005. p. 14–30. 3.
Healthy People. Foundation health measure report: health-related quality of life and well-being. Office of Disease Prevention and Health Promotion. 2020. https://www.healthypeople.gov/sites/default/files/HRQoLWBFullReport.pdf . Accessed May 15 2020.
Djärv T, Lagergren P. Quality of life after esophagectomy for cancer. Expert Rev Gastroenterol Hepatol. 2012;6(1):115–22. https://doi.org/10.1586/egh.11.91.
We gratefully acknowledge the research support for the study from the Kress Family Esophageal Cancer Research Fund and the Kress Family Chair in Esophageal Cancer.
Conflict of interest
The authors declare that they have no conflicts of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
About this article
Cite this article
Darling, G.E., Sulman, J., Espin-Garcia, O. et al. Does it matter how we evaluate HRQOL? Longitudinal comparison of the EORTC QLQ-C30/QLQ-OG25 and FACT-E. J Cancer Surviv (2020). https://doi.org/10.1007/s11764-020-00957-w
- Health-related quality of life instruments
- Longitudinal study
- Esophageal cancer
- EORTC QLQ-C30 OG25